Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment?
- PMID: 15819504
Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment?
Abstract
Background: It has recently been suggested that statins could slow the progression of aortic stenosis, but this hypothesis has not been validated in large series. Moreover, there is little information about the role of statin treatment in patients with aortic valve sclerosis.
Methods: From our database 1988--2002, we retrospectively identified 1136 consecutive patients with aortic valve sclerosis (peak aortic velocity [Vmax] > 1.5 and < 2 m/s), or mild to moderate aortic stenosis (Vmax 2.0-3.9 m/s) and with > or = 2 echocardiographic studies > or = 6 months apart; 121 (11 %) were treated with statins. As a control group we randomly selected 121 age-gender-matched patients not treated with statins, with similar initial Vmax.
Results: The mean follow-up duration was 54+/-34 months in the statin group, and 50+/-33 months in controls (p = 0.35). There were no differences between statin-treated patients and controls with respect to age, gender, and prevalence of hypertension. More patients in the statin group had documented hypercholesterolemia, diabetes, or had proven coronary artery disease. Overall, the rate of change of Vmax was not different between statin-treated patients and controls (0.13+/-0.24 vs 0.14+/-0.19 m/s/year, p = 0.72). However, in the subgroup of patients with aortic valve sclerosis (n = 52, 26 statin-treated, 26 controls), the rate of change of Vmax was significantly lower in statin-treated patients (0.04+/-0.04 vs 0.08+/-0.06 m/s/year, p = 0.007).
Conclusions: The results of our retrospective study show that statins could be beneficial in retarding the progression of valvular aortic sclerosis to aortic stenosis. This suggests that statins retard the progression of aortic valve lesion in its early stage, a finding that may have important implications in the management of this very common disease.
Similar articles
-
Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis.Am J Cardiol. 2008 Sep 15;102(6):738-42. doi: 10.1016/j.amjcard.2008.04.056. Epub 2008 Jun 26. Am J Cardiol. 2008. PMID: 18773999
-
Effect of statin treatment on aortic valve and coronary artery calcification.J Heart Valve Dis. 2007 Jul;16(4):378-86. J Heart Valve Dis. 2007. PMID: 17702362
-
[Can we prevent the progression of aortic valve sclerosis and stenosis? The need for a prospective, randomized trial].Ital Heart J Suppl. 2005 Jul;6(7):403-12. Ital Heart J Suppl. 2005. PMID: 16082823 Review. Italian.
-
[Statins in aortic stenosis].Med Pregl. 2009;62 Suppl 3:101-4. Med Pregl. 2009. PMID: 19702126 Review. Serbian.
-
Hydroxymethylglutaryl coenzyme-a reductase inhibitors delay the progression of rheumatic aortic valve stenosis a long-term echocardiographic study.J Am Coll Cardiol. 2009 May 19;53(20):1874-9. doi: 10.1016/j.jacc.2009.01.064. J Am Coll Cardiol. 2009. PMID: 19442887
Cited by
-
Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients.Heart Vessels. 2011 May;26(3):252-7. doi: 10.1007/s00380-010-0052-x. Epub 2010 Nov 10. Heart Vessels. 2011. PMID: 21063877
-
Is there a role of statins in the prevention of aortic biological prostheses degeneration.Cardiovasc Ultrasound. 2006 Jun 29;4:26. doi: 10.1186/1476-7120-4-26. Cardiovasc Ultrasound. 2006. PMID: 16805917 Free PMC article. Review.
-
Medical management of symptomatic severe aortic stenosis in patients non-eligible for transcatheter aortic valve implantation.J Geriatr Cardiol. 2020 Nov 28;17(11):704-709. doi: 10.11909/j.issn.1671-5411.2020.11.002. J Geriatr Cardiol. 2020. PMID: 33343649 Free PMC article. No abstract available.
-
Could the Hemodynamic Progression of Aortic Valve Stenosis be Slowed Pharmacologically? The Unsolved Dilemma.Rev Cardiovasc Med. 2025 Feb 12;26(2):26537. doi: 10.31083/RCM26537. eCollection 2025 Feb. Rev Cardiovasc Med. 2025. PMID: 40026530 Free PMC article. No abstract available.
-
Aortic valve sclerosis is a high predictive marker of systemic endothelial dysfunction in hypertensive patients.Herz. 2013 Dec;38(8):915-21. doi: 10.1007/s00059-013-3763-9. Epub 2013 Feb 13. Herz. 2013. PMID: 23400346
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials